Evolving Insights in the Pathogenesis and Therapy of Cutaneous T‐cell lymphoma (Mycosis Fungoides and Sezary Syndrome)
Open Access
- 25 August 2011
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 155 (2), 150-166
- https://doi.org/10.1111/j.1365-2141.2011.08852.x
Abstract
Cutaneous T‐cell lymphomas (CTCL) are a heterogeneous group of malignancies derived from skin‐homing T cells. The most common forms of CTCL are Mycosis Fungoides (MF) and Sezary Syndrome (SS). Accurate diagnosis remains a challenge due to the heterogeneity of presentation and the lack of highly characteristic immunophenotypical and genetic markers. Over the past decade molecular studies have improved our understanding of the biology of CTCL. The identification of gene expression differences between normal and malignant T‐cells has led to promising new diagnostic and prognostic biomarkers that now need validation to be incorporated into clinical practice. These biomarkers may also provide insight into the mechanism of development of CTCL. Additionally, treatment options have expanded with the approval of new agents, such as histone deacetylase inhibitors. A better understanding of the cell biology, immunology and genetics underlying the development and progression of CTCL will allow the design of more rational treatment strategies for these malignancies. This review summarizes the clinical epidemiology, staging and natural history of MF and SS; discusses the immunopathogenesis of MF and the functional role of the malignant T‐cells; and reviews the latest advances in MF and SS treatment.This publication has 200 references indexed in Scilit:
- MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndromeCell Death & Disease, 2011
- NF-kappa B addiction and its role in cancer: 'one size does not fit all'Oncogene, 2011
- Histone deacetylase inhibitors in Hodgkin lymphomaInvestigational New Drugs, 2010
- Type I interferon: friend or foe?The Journal of Experimental Medicine, 2010
- Novel approach to gene expression profiling in Sézary syndromeBritish Journal of Dermatology, 2010
- Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expressionProceedings of the National Academy of Sciences of the United States of America, 2010
- Psoralen plus ultraviolet A ± interferon-α treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-κB and T-cell receptor pathwaysBritish Journal of Dermatology, 2009
- Lack of Suppressive CD4+CD25+FOXP3+ T Cells in Advanced Stages of Primary Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 2006
- The Role of Toll-like Receptors in the Pathogenesis and Treatment of Dermatological DiseaseJournal of Investigative Dermatology, 2005
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002